• LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Reata Pharmaceuticals, Inc. for Securities Fraud, Expanding the Cla... ACCESS Newswire Fri, 02 May 2025 15:47:03 GMT

• press release distribution & pr platform ACCESS Newswire Fri, 02 May 2025 15:47:02 GMT

• biogen easily tops earnings forecasts as leqembi, skyclarys sales soar MSN Fri, 02 May 2025 07:54:03 GMT

• is biogen at the 'start of a turnaround' on its quarterly beat? MSN Thu, 01 May 2025 11:01:38 GMT

• biogen easily tops earnings forecasts as leqembi, skyclarys sales soar MSN Thu, 01 May 2025 11:01:38 GMT

• friedreich’s ataxia clinical trials and studies 2025: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Mon, 28 Apr 2025 18:28:00 GMT

• Press Release Distribution & PR Platform ACCESS Newswire Fri, 25 Apr 2025 04:45:55 GMT

• mhra approves first uk treatment for friedreich’s ataxia The Pharma Letter Thu, 24 Apr 2025 09:46:12 GMT

• autosomal dominant polycystic kidney disease market future openPR.com Thu, 10 Apr 2025 12:57:00 GMT

• shareholder alert: levi & korsinsky, llp reminds shareholders of reata pharmaceuticals, inc. of a class action lawsuit and a lead ... ACCESS Newswire Thu, 03 Apr 2025 02:04:28 GMT

• update on regulatory review of lecanemab for early alzheimer’s disease by the european commission Biogen Tue, 01 Apr 2025 10:03:42 GMT

• CNS Pharmaceuticals Inc. (CNSP) reports earnings qz.com Mon, 31 Mar 2025 07:00:00 GMT

• biogen initiates phase 3 study of felzartamab for the treatment of late antibody-mediated rejection (amr) in kidney transplant pat... Biogen | Investor Relations Tue, 11 Mar 2025 11:31:15 GMT

• AKPKD Pipeline 2024: Key Companies, MOA, ROA, and Clinical openPR.com Tue, 04 Mar 2025 08:00:00 GMT

• polycystic kidney disease pipeline 2025: fda approvals openPR.com Wed, 26 Feb 2025 08:00:00 GMT

• shareholder alert: levi & korsinsky, llp reminds shareholders of reata pharmaceuticals, inc. of a class action lawsuit and a lead ... ACCESS Newswire Wed, 26 Feb 2025 02:04:42 GMT

• reata pharmaceuticals, inc. to host earnings call ACCESS Newswire Fri, 21 Feb 2025 06:55:53 GMT

• CEO Viehbacher Confident In Biogen’s Portfolio, But Open To Additions insights.citeline.com Thu, 13 Feb 2025 08:00:00 GMT

• Biogen axes asset from $7.3B buyout, along with Alzheimer’s and Parkinson’s prospects Fierce Biotech Wed, 12 Feb 2025 08:00:00 GMT

• Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition Yahoo Wed, 12 Feb 2025 08:00:00 GMT

• professor paola giunti wins creating impact through knowledge exchange award UCL - London's Global University Wed, 05 Feb 2025 08:00:00 GMT

• larimar started at buy by truist on friedreich's ataxia drug MSN Thu, 30 Jan 2025 23:27:16 GMT

• larimar started at buy by truist on friedreich's ataxia drug MSN Wed, 29 Jan 2025 22:18:56 GMT

• larimar started at buy by truist on friedreich's ataxia drug MSN Tue, 28 Jan 2025 08:00:00 GMT

• reata pharmaceuticals inc. (reta) stock biogen deal contestable The Market Periodical Thu, 16 Jan 2025 15:15:35 GMT

• alport syndrome treatment market 2034: clinical trials, ema, pdma, fda approvals, medication, therapies, and companies by delveins... The Globe and Mail Wed, 15 Jan 2025 02:05:25 GMT

• autosomal dominant polycystic kidney disease market overview, openPR Fri, 27 Dec 2024 08:00:00 GMT

• plano-based drug developer reata raises $505 million, expects to double to 400 employees by end of 2020 Oficjalny Portal Gminy Brzesko Wed, 18 Dec 2024 18:03:55 GMT

• reata completes new anti-inflammatory drugs agreement OutSourcing-Pharma.com Thu, 28 Nov 2024 01:45:58 GMT

• reata pharmaceuticals, inc. (nasdaq: reta) shareholder class action alert Marketscreener.com Sat, 23 Nov 2024 10:13:30 GMT

• Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D BioSpace Wed, 20 Nov 2024 08:00:00 GMT

• friedreich's ataxia market to boost revenue potential, openPR Fri, 15 Nov 2024 08:00:00 GMT

• biopharma layoffs roundup Contract Pharma Tue, 12 Nov 2024 09:12:06 GMT

• biopharma layoffs roundup Contract Pharma Mon, 11 Nov 2024 08:00:00 GMT

• autosomal dominant polycystic kidney disease (akpkd) clinical openPR Mon, 11 Nov 2024 08:00:00 GMT

• Study says top launches were for drugs for untreated diseases Fierce Pharma Wed, 06 Nov 2024 08:00:00 GMT

• extensive growth opportunities to be witnessed by autosomal openPR Wed, 06 Nov 2024 08:00:00 GMT

• friedreich's ataxia market to grow at a substantial growth rate openPR Wed, 06 Nov 2024 08:00:00 GMT

• Biogen brings in medical chief as CFO plans retirement; MacroGenics CEO announces departure Endpoints News Fri, 01 Nov 2024 07:00:00 GMT

• a halloween scare: ambiguity in loan terms JD Supra Tue, 29 Oct 2024 07:00:00 GMT

• italy’s angelini pens $360m biobucks pact for cureverse’s phase 1 brain disorder drug Fierce Biotech Mon, 21 Oct 2024 07:00:00 GMT

• biopharma layoffs roundup Contract Pharma Tue, 15 Oct 2024 07:00:00 GMT

• nrf2 pathway activators market growing massively by-reata pharmaceuticals, cayman chemical company, biophore, abcam, bio – indiapo... IndiaPolitics.com Tue, 15 Oct 2024 04:07:37 GMT

• new higher dose nusinersen efficacy and safety data presented at world muscle society congress, highlight potential to maximize be... Biogen Tue, 08 Oct 2024 07:00:00 GMT

• Judo kickstarts with $100M to develop genetic medicines that strike out kidney disease Fierce Biotech Mon, 07 Oct 2024 07:00:00 GMT

• for beaten-down maker of alzheimer’s drug, good enough will do MSN Sun, 22 Sep 2024 08:14:22 GMT

• friedreich's ataxia market to show remarkable growth trends openPR Tue, 03 Sep 2024 17:16:00 GMT

• friedreich’s ataxia drugs market is projected to reach us$ 3.49 billion by 2034 | fact.mr report GlobeNewswire Tue, 20 Aug 2024 07:00:00 GMT

• shareholder alert: levi & korsinsky, llp notifies shareholders of reata pharmaceuticals, inc. of a class action lawsuit and a lead... Marketscreener.com Tue, 13 Aug 2024 21:06:15 GMT

• Last year, Biogen’s CEO said no risky deals. Now, he’s ready to be bold Fierce Biotech Thu, 01 Aug 2024 07:00:00 GMT

• friedreich's ataxia market detailed in new research report 2024 |reata pharmaceuticals, inc., retrotope inc., minoryx openPR Wed, 31 Jul 2024 07:00:00 GMT

• biogen alert: bragar eagel & squire, p.c. is investigating GlobeNewswire Fri, 26 Jul 2024 01:00:00 GMT

• biogen alert: bragar eagel & squire, p.c. is investigating GlobeNewswire Thu, 25 Jul 2024 07:00:00 GMT

• Geron losing commercial chief shortly after first FDA approval Fierce Pharma Wed, 24 Jul 2024 07:00:00 GMT

• chronic kidney disease fda approvals, emerging drugs, openPR Tue, 16 Jul 2024 10:14:00 GMT

• friedreich's ataxia market to grow at a substantial growth GlobeNewswire Tue, 16 Jul 2024 07:00:00 GMT

• key takeaways from biogen analyst ratings Quantisnow Fri, 12 Jul 2024 15:00:43 GMT

• why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report? Yahoo News Australia Wed, 10 Jul 2024 18:09:02 GMT

• reata pharmaceuticals | biotechnology | the pharmaletter The Pharma Letter Fri, 05 Jul 2024 11:19:19 GMT

• chronic kidney disease pipeline 2024 | boehringer ingelheim, openPR Wed, 03 Jul 2024 10:13:00 GMT

• diabetic nephropathy market size, insights 2031 by key vendors- mitsubishi tanabe pharma corporation, reata ... openPR Tue, 02 Jul 2024 16:29:00 GMT

• biogen completes acquisition of human immunology biosciences Quantisnow Tue, 02 Jul 2024 13:29:03 GMT

• why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report? Yahoo News Australia Mon, 01 Jul 2024 14:21:50 GMT

• reata pharmaceuticals, inc. to report third quarter 2021 financial results and to provide an update on development programs on nov... Quantisnow Sun, 30 Jun 2024 10:21:14 GMT

• reata pharmaceuticals announces presentations at the american society of nephrology kidney week 2021 Quantisnow Sun, 30 Jun 2024 09:57:04 GMT

• reata pharmaceuticals, inc. announces proposed public offering of class a common stock Quantisnow Sun, 30 Jun 2024 09:56:53 GMT

• reata pharmaceuticals announces participation in the guggenheim 2022 immunology and neurology conference and the stifel 2022 healt... Quantisnow Sun, 30 Jun 2024 09:46:50 GMT

• why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report? Yahoo News Australia Sun, 30 Jun 2024 01:20:00 GMT

• reata (reta) omaveloxolone program faces delay on fda update Yahoo Movies UK Sat, 29 Jun 2024 20:19:49 GMT

• why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report? Yahoo News Australia Fri, 28 Jun 2024 09:33:45 GMT

• cantor fitzgerald reiterates reata pharmaceuticals inc - (reta) overweight recommendation MSN Fri, 28 Jun 2024 08:13:16 GMT

• reata pharmaceuticals (nasdaq:reta) shareholders have endured a 73% loss from investing in the stock a year ago Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT

• reata (reta) confirms omaveloxolone nda filing in q1 2022 Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT

• biogen is pursuing more dealmaking this year, with plans to spend up to $8b Endpoints News Thu, 27 Jun 2024 07:00:00 GMT

• reata pharmaceuticals, inc.'s stock is down 14%, but insiders still have about us$163k in profit after buying earlier this ... Yahoo New Zealand News Thu, 27 Jun 2024 05:33:00 GMT

• pharma m&a: the top high value deals in 2023 Pharmaceutical Technology Wed, 26 Jun 2024 07:00:00 GMT

• Top 10 smartest deals in biopharma Fierce Biotech Mon, 24 Jun 2024 07:00:00 GMT

• polycystic kidney disease pipeline insights 2024: therapies, clinical trials, and market trends openPR Thu, 20 Jun 2024 13:48:00 GMT

• reata pharmaceuticals (nasdaq:reta) shareholders have endured a 84% loss from investing in the stock three ... Yahoo New Zealand News Thu, 20 Jun 2024 04:56:00 GMT

• friedreich ataxia Biogen Mon, 17 Jun 2024 21:05:18 GMT

• friedreich’s ataxia market to grow at a substantial growth rate during the forecast period | reata pharmaceuticals, aavantibio, mi... Barchart Thu, 13 Jun 2024 07:00:00 GMT

• friedreich's ataxia market to grow at a substantial growth rate during the forecast period | reata pharmaceuticals ... Barchart Thu, 13 Jun 2024 07:00:00 GMT

• reata pharmaceuticals, inc. (reta) moves 7.0% higher: will this strength last? Yahoo News Australia Wed, 12 Jun 2024 02:21:05 GMT

• reata pharmaceuticals, inc. (nasdaq:reta): when will it breakeven? Yahoo Movies UK Fri, 07 Jun 2024 07:16:52 GMT

• larimar: friedreich's ataxia drug with significant potential MSN Mon, 03 Jun 2024 19:06:04 GMT

• reata pharmaceuticals, inc. (reta) stock jumps 20.6%: will it continue to soar? Yahoo New Zealand News Fri, 31 May 2024 04:37:00 GMT

• why is reata pharmaceuticals, inc. (reta) up 53.1% since last earnings report? Yahoo Sport Australia Thu, 30 May 2024 18:03:28 GMT

• events & presentations | biogen Biogen | Investor Relations Thu, 30 May 2024 06:36:52 GMT

• presentations Biogen | Investor Relations Thu, 30 May 2024 06:36:52 GMT

• reata pharmaceuticals, inc. (reta) reports q2 loss, tops revenue estimates Yahoo Singapore News Wed, 29 May 2024 07:12:42 GMT

• reata pharmaceuticals, inc. (reta) stock jumps 20.6%: will it continue to soar? Yahoo New Zealand News Tue, 28 May 2024 22:02:58 GMT

• friedreich's ataxia market to observe impressive growth during the forecast period (2024-2034), evaluates delveinsight openPR Tue, 28 May 2024 07:00:00 GMT

• is reata pharmaceuticals, inc.'s (nasdaq:reta) ceo pay fair? Yahoo Lifestyle UK Sun, 26 May 2024 18:08:54 GMT

• reata pharmaceuticals, inc. (reta) reports q4 loss, lags revenue estimates Yahoo Lifestyle Australia Sat, 25 May 2024 00:47:00 GMT

• reata (reta) jumps: stock rises 5. 6% Yahoo News Australia Fri, 24 May 2024 17:34:24 GMT

• biogen to expand immunology and rare disease portfolio with $1.8bn hi-bio acquisition PMLiVE Thu, 23 May 2024 07:00:00 GMT

• goodwin, covington shepherd biogen’s $1.8bn acquisition of rare disease drugmaker The Global Legal Post Thu, 23 May 2024 07:00:00 GMT

• stifel downgrades reata pharmaceuticals inc - (reta) MSN Wed, 22 May 2024 09:07:23 GMT

• Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition MedCity News Wed, 22 May 2024 07:00:00 GMT

• biogen makes $1.15b buy for arch’s hi-bio to expand immunology pipeline Endpoints News Wed, 22 May 2024 07:00:00 GMT

• biogen in up to $1.8 bln deal as rare diseases take center stage Reuters Wed, 22 May 2024 07:00:00 GMT

• full steam ahead for friedreich's ataxia-focused larimar The Pharma Letter Wed, 22 May 2024 07:00:00 GMT

• larimar resumes nomlabofusp programme after fda lifts partial hold Clinical Trials Arena Tue, 21 May 2024 07:00:00 GMT

• reata pharmaceuticals, inc. (reta) reports q4 loss, lags revenue estimates Yahoo Lifestyle Australia Mon, 20 May 2024 00:37:31 GMT

• reata pharmaceuticals, inc. (reta) reports q1 loss, lags revenue estimates Yahoo Canada Shine On Sat, 18 May 2024 22:35:03 GMT

• reata pharmaceuticals, inc.'s stock is down 14%, but insiders still have about us$163k in profit after buying earlier this ... Yahoo Movies Canada Sat, 18 May 2024 16:53:12 GMT

• intel, reata pharma and roku rally, and other movers MSN Fri, 17 May 2024 10:20:22 GMT

• earnings preview: reata pharmaceuticals, inc. (reta) q3 earnings expected to decline Yahoo Lifestyle Australia Thu, 16 May 2024 23:57:08 GMT

• is the options market predicting a spike in reata pharmaceuticals (reta) stock? Yahoo News UK Thu, 16 May 2024 07:46:12 GMT

• biogen ceo looks for small deals while alzheimer’s drug ramps up themiddlemarket.com Thu, 16 May 2024 07:00:00 GMT

• biogen ceo looks for small deals while alzheimer's drug ramps up Bloomberg Thu, 16 May 2024 07:00:00 GMT

• is the options market predicting a spike in reata pharmaceuticals (reta) stock? Yahoo News UK Tue, 14 May 2024 00:01:59 GMT

• reata (reta) up more than 12% ytd: what's driving the rally? Yahoo Movies Canada Mon, 13 May 2024 14:24:35 GMT

• why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report? Yahoo Movies Canada Mon, 13 May 2024 02:53:48 GMT

• rare diseases - bardoxolone, nephrology and hepatology The Pharma Letter Sun, 12 May 2024 01:46:30 GMT

• rare diseases - bardoxolone, cns diseases The Pharma Letter Sun, 12 May 2024 01:45:27 GMT

• is the options market predicting a spike in reata pharmaceuticals (reta) stock? Yahoo News UK Sat, 11 May 2024 18:50:49 GMT

• rare diseases - nephrology and hepatology, bardoxolone The Pharma Letter Sat, 11 May 2024 18:08:49 GMT

• one to watch companies - us fda, vyjuvek The Pharma Letter Sat, 11 May 2024 17:47:17 GMT

• reata pharmaceuticals reports q1 loss per share of $0.32 Reuters Sat, 11 May 2024 07:00:00 GMT

• reata pharmaceuticals, inc. (reta) down 37.8% since last earnings report: can it rebound? Yahoo Lifestyle UK Fri, 10 May 2024 13:52:11 GMT

• positive week for reata pharmaceuticals, inc. (nasdaq:reta) institutional investors who lost 76% over the past year Yahoo Movies UK Fri, 10 May 2024 13:52:11 GMT

• who just ramped up their shares in reata pharmaceuticals inc (nasdaq:reta)? Yahoo Movies UK Fri, 10 May 2024 06:56:00 GMT

• reata pharmaceuticals, inc. (reta) reports q4 loss, lags revenue estimates Yahoo Canada Shine On Fri, 10 May 2024 01:20:00 GMT

• one to watch companies - us fda, fyarro, reata pharmaceuticals The Pharma Letter Wed, 08 May 2024 23:36:46 GMT

• reata pharmaceuticals, inc.'s stock is down 14%, but insiders still have about us$163k in profit after buying earlier this ... Yahoo Movies Canada Wed, 08 May 2024 20:04:20 GMT

• akpkd pipeline drugs analysis report (2024 updates): fda approvals, clinical trials, therapies, moa, roa by ... openPR Wed, 08 May 2024 15:16:00 GMT

• cantor fitzgerald reiterates reata pharmaceuticals inc - (reta) neutral recommendation MSN Wed, 08 May 2024 05:32:26 GMT

• shareholders will probably not have any issues with reata pharmaceuticals, inc.'s (nasdaq:reta) ceo ... Yahoo Lifestyle UK Wed, 08 May 2024 01:04:33 GMT

• strength seen in reata pharmaceuticals, inc. (reta): can its 3% jump turn into more strength? Yahoo Movies UK Tue, 07 May 2024 14:06:23 GMT

• does biogen's latest $1.5 billion-dollar move make it a buy? MSN Tue, 07 May 2024 11:44:16 GMT

• one to watch companies - us fda, voclosporin The Pharma Letter Tue, 07 May 2024 10:26:25 GMT

• investors ignore increasing losses at reata pharmaceuticals (nasdaq:reta) as stock jumps 4.7% this past week Yahoo Canada Shine On Tue, 07 May 2024 01:32:00 GMT

• focus on - drug trial, anti-arthritics/rheumatics, bardoxolone The Pharma Letter Mon, 06 May 2024 23:15:28 GMT

• focus on - licensing, astrazeneca, bardoxolone The Pharma Letter Mon, 06 May 2024 20:44:39 GMT

• focus on - bayer, oncology, reata pharmaceuticals The Pharma Letter Mon, 06 May 2024 19:15:17 GMT

• aacr annual meeting 2018 - rare diseases, bardoxolone The Pharma Letter Mon, 06 May 2024 10:51:38 GMT

• u.s. fda approves reata's rare genetic disorder drug Yahoo Movies Canada Sun, 05 May 2024 14:13:48 GMT

• reata pharmaceuticals, inc. (reta) stock jumps 20.6%: will it continue to soar? Yahoo Singapore News Sun, 05 May 2024 12:16:01 GMT

• investors ignore increasing losses at reata pharmaceuticals (nasdaq:reta) as stock jumps 4.7% this past week Yahoo Canada Shine On Sun, 05 May 2024 00:11:00 GMT

• reata (reta) q1 earnings surpass estimates, revenues miss Yahoo Lifestyle UK Sat, 04 May 2024 16:14:14 GMT

• reata pharmaceuticals, inc. (nasdaq:reta) is expected to breakeven in the near future Yahoo Movies Canada Sat, 04 May 2024 15:32:03 GMT

• reata pharmaceuticals, inc. (reta) reports q1 loss, lags revenue estimates Yahoo News UK Fri, 03 May 2024 17:11:46 GMT

• reata (reta) q2 earnings miss, revenues down y/y, stock down Yahoo New Zealand News Fri, 03 May 2024 05:09:27 GMT

• who just ramped up their shares in reata pharmaceuticals inc (nasdaq:reta)? Yahoo Movies UK Fri, 03 May 2024 04:00:24 GMT

• radiodermatitis market and epidemiology 2032: treatment market, therapies, companies, fda approvals ... Barchart Tue, 30 Apr 2024 13:01:00 GMT

• positive week for reata pharmaceuticals, inc. (nasdaq:reta) institutional investors who lost 76% over the past year Yahoo Movies UK Mon, 29 Apr 2024 11:33:24 GMT

• reata pharmaceuticals, inc. (reta) down 37.8% since last earnings report: can it rebound? Yahoo Lifestyle UK Sat, 27 Apr 2024 10:49:12 GMT

• biopharma layoffs roundup Contract Pharma Fri, 26 Apr 2024 07:00:00 GMT

• biogen reports net income of $393.4m in q1 2024 Pharmaceutical Technology Thu, 25 Apr 2024 07:00:00 GMT

Reata Pharmaceuticals, Inc
(NASDAQ:RETA)

Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs,...

Website: http://www.reatapharma.com

Founded: 2002

Full Time Employees: 220

Sector: Healthcare

Industry: Biotechnology

Pharmaceuticals

Share this website to your friends

Reata Pharmaceuticals, Inc(NASDAQ:RETA)

Reata Pharmaceuticals, Inc
(NASDAQ:RETA)